Literature DB >> 11705373

Peptide inhibitors of HIV-1 integrase dissociate the enzyme oligomers.

R G Maroun1, S Gayet, M S Benleulmi, H Porumb, L Zargarian, H Merad, H Leh, J F Mouscadet, F Troalen, S Fermandjian.   

Abstract

Integration of HIV-1 genome into host cell chromosome is mediated by viral integrase (IN). The IN catalytic core (CC, IN(50-212)) dimerizes through mutual interactions of its alpha1 and alpha5 helices. Peptides INH1 and INH5 reproducing these helix sequences strongly inhibited IN. For instance, an IC(50) of 80 nM was determined for INH5 in integration assays using wild-type IN (wtIN). In size exclusion chromatography, INH1 and INH5 perturbed the association-dissociation equilibrium of both dmIN (IN(1-288)/F185K/C280S) and CC, leading to monomers as surviving species, while in circular dichroism, binding of peptides to dmIN altered the protein conformation. Thus, enzyme deactivation, subunit dissociation, and protein unfolding are events which parallel one another. The target of INH5 in the enzyme was then identified. In fluorescence spectroscopy, C(0.5) values of 168 and 44 nM were determined for the binding affinity of INH5 to IN and CC, respectively, at 115 nM subunit concentration, while interaction of INH5 with INH1 was found stronger than interaction of INH5 with itself (23 times larger in term of dissociation constants). These results strongly suggested that the alpha1 helix is the privileged target of INH5. The latter could serve as a lead for the development of new chemotherapeutic agents against HIV-1.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11705373     DOI: 10.1021/bi011328n

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  24 in total

Review 1.  Allosteric inhibitor development targeting HIV-1 integrase.

Authors:  Laith Q Al-Mawsawi; Nouri Neamati
Journal:  ChemMedChem       Date:  2011-01-12       Impact factor: 3.466

2.  The dimerization domain of the HIV-1 capsid protein binds a capsid protein-derived peptide: a biophysical characterization.

Authors:  María T Garzón; María C Lidón-Moya; Francisco N Barrera; Alicia Prieto; Javier Gómez; Mauricio G Mateu; José L Neira
Journal:  Protein Sci       Date:  2004-06       Impact factor: 6.725

3.  New class of HIV-1 integrase (IN) inhibitors with a dual mode of action.

Authors:  Manuel Tsiang; Gregg S Jones; Anita Niedziela-Majka; Elaine Kan; Eric B Lansdon; Wayne Huang; Magdeleine Hung; Dharmaraj Samuel; Nikolai Novikov; Yili Xu; Michael Mitchell; Hongyan Guo; Kerim Babaoglu; Xiaohong Liu; Romas Geleziunas; Roman Sakowicz
Journal:  J Biol Chem       Date:  2012-04-25       Impact factor: 5.157

4.  Peptide-mediated interference with influenza A virus polymerase.

Authors:  Alexander Ghanem; Daniel Mayer; Geoffrey Chase; Werner Tegge; Ronald Frank; Georg Kochs; Adolfo García-Sastre; Martin Schwemmle
Journal:  J Virol       Date:  2007-05-09       Impact factor: 5.103

Review 5.  HIV integrase inhibitors: 20-year landmark and challenges.

Authors:  Mathieu Métifiot; Christophe Marchand; Yves Pommier
Journal:  Adv Pharmacol       Date:  2013

6.  Affinities between the binding partners of the HIV-1 integrase dimer-lens epithelium-derived growth factor (IN dimer-LEDGF) complex.

Authors:  Manuel Tsiang; Gregg S Jones; Magdeleine Hung; Susmith Mukund; Bin Han; Xiaohong Liu; Kerim Babaoglu; Eric Lansdon; Xiaowu Chen; Jacob Todd; Terrence Cai; Nikos Pagratis; Roman Sakowicz; Romas Geleziunas
Journal:  J Biol Chem       Date:  2009-09-28       Impact factor: 5.157

7.  Prospective strategies for targeting HIV-1 integrase function.

Authors:  Yang Luo; Mark A Muesing
Journal:  Future Med Chem       Date:  2010-07       Impact factor: 3.808

8.  Identification of an inhibitor-binding site to HIV-1 integrase with affinity acetylation and mass spectrometry.

Authors:  Nick Shkriabai; Sachindra S Patil; Sonja Hess; Scott R Budihas; Robert Craigie; Terrence R Burke; Stuart F J Le Grice; Mamuka Kvaratskhelia
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

Review 9.  Piecing together the structure of retroviral integrase, an important target in AIDS therapy.

Authors:  Mariusz Jaskolski; Jerry N Alexandratos; Grzegorz Bujacz; Alexander Wlodawer
Journal:  FEBS J       Date:  2009-04-14       Impact factor: 5.542

10.  An unusual helix turn helix motif in the catalytic core of HIV-1 integrase binds viral DNA and LEDGF.

Authors:  Hayate Merad; Horea Porumb; Loussiné Zargarian; Brigitte René; Zeina Hobaika; Richard G Maroun; Olivier Mauffret; Serge Fermandjian
Journal:  PLoS One       Date:  2009-01-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.